by Pravin Kendrekar
The first comprehensive and up-to-date compilation of modern diagnostic and treatment methods for triple negative breast cancer
In
Drug and Therapy Development for Triple Negative Breast Cancer, a team
of distinguished practitioners delivers an in-depth and authoritative
discussion of contemporary methods for treating triple negative breast
cancer (TNBC). The editors have included material that covers its
molecular causes, initial detection, diagnostic tools, treatment
procedures, pharmacology, and new and experimental therapies―including
nanotherapeutics and photothermal therapies.
As
the first comprehensive compilation of modern treatment methods for
TNBC, this reference is an unmatched source of information about
current and future treatment approaches, including machine learning
methods for earlier detection and more accurate diagnosis. Readers will
also find:
- A thorough introduction to HER receptors in breast cancers
- Comprehensive
explorations of the etiology and therapy of hormone receptor-positive
breast cancer and the early-stage diagnosis of breast cancer
- Application of artificial intelligence to breast cancer diagnosis
- New insights on the role of DNA replication stress and genome instability in breast cancer
Perfect
for medicinal and pharmaceutical chemists, Drug and Therapy Development
for Triple Negative Breast Cancer will also benefit oncologists and
professionals working in the pharmaceutical industry or in hospital
settings.
